Our Approach

When we see major trends and structural changes happening in one of our core sectors, we set up and invest in platform companies/roll-up models to make concentrated and focused bets and acquisitions.

These platform companies offer centralized services and leadership – especially business development – and make most sense sectors where founders and innovators are often amazing innovators but lack the commercial or entrepreneurial skillset.

We have raised more than US$ 1 billion outside money in recent years for our various platform companies.

A few selected platform companies:

We take active minority stakes in listed companies mainly through IPOs & SPACs, but sometimes also later in a company’s life cycle.

We offer our listed companies the same attention and value-add as we give our venture portfolio.

Primarily, we initiate and sponsor our own SPACs – often together with strategic partners – focusing on certain high growth industries and/or regions.

Additionally, we invest in the SPACs of other sponsors, offering an entrepreneurial, long-term investor & partner who not only provides capital, but deal flow too.

A few selected portfolio companies:

Elevat3 Capital is Apeiron's Germany-focused venture capital arm.

Elevat3 invests in European companies, with Peter Thiel's Founders Fund as a strategic partner. Elevat3's focus is on Germany, stage- and sector-agnostic, but concentrating on the key Apeiron sectors.

With Elevat3, we fully deploy Apeiron's "extreme hands-on" approach.

We co-invest with top-tier VCs through Presight Capital - Apeiron's flagship venture capital fund.

Presight has invested in more than 60 companies alongside leading funds and investors such as Thiel Capital, Valar Ventures, Founders Fund, Orbimed, 8VC, Khosla Ventures, Holtzbrinck Ventures, Charles River Ventures, Amgen, SoftBank, Travis Kalanick, Elon Musk, Cherry Ventures, Project A, Third Prime, DCVC Bio, Tuesday Capital, Viking, Felix Capital, 468 Capital, Clocktower Ventures, Bill Gates, and Gigafund.

To complement and diversify our portfolio, we invest globally in venture capital funds via our Fund-of-Funds Apeiron Partners.

We invest in access-constrained, remarkable fund managers who have a high conviction approach and bold thesis for the future. Our core focus is emerging early-stage venture funds, but we also construct selected positions in top performing established funds.

re.Mind is a venture capital fund dedicated to the brain and mind.

It is the largest venture fund globally solely dedicated to investing into mental and neurological health.

Our focus areas include brain-computer interfaces, personalization, new pharmacology, new modalities, and more.

Limestone Capital is a fully integrated investment firm focused on the hospitality sector.

Limestone utilizes a highly selective investment approach focused on high quality, differentiated assets with attractive risk-adjusted returns. The firm focuses on destinations within the EU where it sources, develops and operates unique properties requiring significant repositioning, management change and quality design.